Biological pathway‐based Alzheimer’s Disease polygenic risk score and proteinopathy
Yuriko Katsumata, Xian Wu, Khine Zin Aung, Inori Tsuchiya, Lincoln MP Shade, Shama D Karanth, Kathryn Gauthreaux, Charles Mock, Walter A Kukull, Erin L Abner, Peter T Nelson, David W Fardo · 2025
Read Biological pathway‐based Alzheimer’s Disease polygenic risk score and proteinopathy by Yuriko Katsumata, Xian Wu, Khine Zin Aung, Inori Tsuchiya, Lincoln MP Shade, Shama D Karanth, Kathryn Gauthreaux, Charles Mock, Walter A Kukull, Erin L Abner, Peter T Nelson, David W Fardo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709564.txt.
Description
Yuriko Katsumata and co-authors built gene risk scores for Alzheimer's disease split by biological pathway in a 2025 study. A polygenic risk score adds up many small genetic effects into one number. A single total score, though, mixes pathways that may drive different kinds of brain damage.
The team had earlier tied genes to three protein problems seen in dementia brains: TDP-43, amyloid with tau, and alpha-synuclein. They built latent measures for each and formed pathway-specific scores. Such scores can test which pathway a person's genes push hardest. That split could sharpen trial design, matching patients to drugs by the biology their genes favor, rather than by symptoms alone.
Catalog record
| CREATOR | Yuriko Katsumata, Xian Wu, Khine Zin Aung, Inori Tsuchiya, Lincoln MP Shade, Shama D Karanth, Kathryn Gauthreaux, Charles Mock, Walter A Kukull, Erin L Abner, Peter T Nelson, David W Fardo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |